No, it is not the same.
I can translate it for you if you want.
this study of Microtransponder is in trail phase....
Sjoerd, maybe you can sent me some info in Dutch via PM, thx.
No, it is not the same.
I can translate it for you if you want.
this study of Microtransponder is in trail phase....
ok...why is this topic so inactive?Why is this topic so inactive? To me this treatment is far more promesing than any drug currently developed....
It is inactive because they have been very quiet about it for a while. We have no new info to discuss. And I don't want to be a downer but this treatment wont be available for everybody. It's invasive and therefore expensive. I think only very severe cases will be able to get this treatment. At least in the beginning, if it works.
Agreed, but in the short term this does give us a better outlook. one might not need to suffer endlessly. It is surgery , so it is invasive, but it is not like they have to cut you open from top to bottom. The vagus nerve is very easily accessible in the neck. They talk about a 45 minute procedure. Loads of poeple of corrective type surgery that is far more invasive and they can pay for it out of there own pocket.
besides....this therapy is a one time deal. What do drugs cost? 500 to a 1000 dollars per year?
I wouldn't get too excited yet.
They told me in Antwerp they have tested it themselves, and it didn't work, sadly
I wouldn't get too excited yet.
They told me in Antwerp they have tested it themselves, and it didn't work, sadly
You need to be more specific. Who are "they"? Do you mean the people behind this? Cause they are in Dallas, not Anwerp. And yes, of course they have tested it, the link that Sjored provided is from the small study they did on 10 patients. That info has been out there for quite some time. The results of that small study can be both positive and negative depending on how you look at things. To me that study is quite optimistic.
5 patients had a good results and 5 had no results. Funny thing is that all the patients that had no results where on either a benzodiazepine or SSRi drug.
Yes and in these articles about the study they use words like "positive results" and "significant reduction".
http://www.utdallas.edu/news/2013/1...Positive-Results-for-Tinnitu-_story-wide.html
http://www.medicalnewstoday.com/articles/269207.php
@Sjoerd
Great, but this nerve stimulation does not solve the jaw clenching / grinding / muscular tension which somatosensory tinnitus patients have. You still need therapy /drugs / time for that.
You need to be more specific. Who are "they"? Do you mean the people behind this? Cause they are in Dallas, not Anwerp.
Hi !
I've just discovered this topic… I did not all understand actually… (yes I'm french ) Could VNS be a treatment for non tonal tinnitus too ?
It is interesting although vague to how it will work (if it works) on humans. Animal testing has even gone to the state of restoring hearing, something that should take precedence but still...
For me it remains a questionable approach. Fine-tuning the human brain? Hard to buy...
Indeed, with mixed results. And only one study! Not much to go on IMO. I do find it really primitive in ways of curing something as complicated as Tinnitus with mere electric current. For all we know that damn thing could cause more neuro- damage... Who is to guarantee it will not? Not to mention that electrode fusion...They have already done a study on humans, it's covered quite well in this thread.
Indeed, with mixed results. And only one study! Not much to go on IMO. I do find it really primitive in ways of curing something as complicated as Tinnitus with mere electric current. For all we know that damn thing could cause more neuro- damage... Who is to guarantee it will not? Not to mention that electrode fusion...
Therapies like this should be considered EXTREMELY experimental and with ambiguous/dangerous results.
I think that if it where to provide positive results we would know by now, don't you?
In 107 patients with an epilepsy etiology related to a brain tumor, seizure reduction was 45% at 3 months and 79% at 24 months with a responder rate of 48% at 3 months and 79% at 24 months.
Seizure reduction of 100% was reported in 7.8% (early) and 3.7% (late) patients at 3 months and 11.8% (early) and 4.5% (late) at 12 months (P = 0.033). Reductions in seizure frequency greater than or equal to 90% for early and late treatment groups were similar: 11.8% (early) and 11.0% (late) at 3 months and 23.5% (early) and 17.0% (late) at 12 months.